ImmunityBio, Inc. (IBRX) has a market capitalization of $7.81B and trades at $7.60. The 52-week range is 1.83-12.43.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -20, Earnings Per Share (EPS) of $-0.38, annual revenue of $113.29M.
The stock has a beta of 0.06, operates in the Healthcare sector.
